NCT04895293View on ClinicalTrials.gov

RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

February 8, 2022

Study Completion Date

March 4, 2022

Conditions

Age Related Macular Degeneration

Interventions

DRUG

RBM-007 Injectable Solution

Sterile solution

Trial Locations (1)

46290

Midwest Eye Institute, Indianapolis

All Listed Sponsors

lead

Maturi, Raj K., M.D., P.C.

INDIV